An interventional study of Physical activity in Liver Transplant, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-06-06.
Sponsored by Mayo Clinic · Not applicable and Interventional
Will adult liver transplant patients who are provided with physical activity (walking) instructions increase their physical activity and perceive an improved quality of life?
Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.
Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Participants will be provided physical activity walking instructions and asked to record their daily activity on an activity log.
Behavioral: Physical activity
Participants will be provided physical activity walking instructions and asked to record their daily activity on an activity log. Participants will be given the International Physical Activity Questionnaire and asked about their quality of life at baseline, at 6 weeks and at 4 months.
Physical Activity Measured by the International Physical Activity Questionnaire (IPAQ)
The IPAQ calculates the metabolic equivalent (MET) score by asking participants the days and minutes exercised in three categories of intensity (vigorous, moderate, and walking) during the previous one week. The following formula is used to calculate the MET: MET=8(vigorous activity) (minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes).
Time frame: Baseline, 6 weeks
Quality of Life at Baseline, 6 Weeks, and 4 Months
Participants reported their perceived quality of life using a scale 1 - 10, with 1 being the worst and 10 being the best.
Time frame: Baseline, 6 weeks, 4 months
Number of Patients Who Document Their Physical Activity
8 participants documented their physical activity at 6 weeks. 6 participants documented their physical activity at 4 months.
Time frame: Baseline to 6 weeks, repeated measure at 4 months
Participants were enrolled at Mayo Clinic in Jacksonville, Florida. Data were collected from April 2014 to September 2014.
| Milestone | Liver Transplant Patients |
|---|---|
| Started | 12 |
| 6 weeks | 8 |
| Completed | 8 |
| Not completed | 4 |
| Withdrew: Withdrawal by subject | 4 |
The IPAQ calculates the metabolic equivalent (MET) score by asking participants the days and minutes exercised in three categories of intensity (vigorous, moderate, and walking) during the previous one week. The following formula is used to calculate the MET: MET=8(vigorous activity) (minutes) + 4 (moderate activity)(minutes) +3.3 (walking activity) (minutes).
| MET | Liver Transplant Patients |
|---|---|
| Baseline | 407 (99 to 14,826) |
| 6 weeks | 1711 (462 to 2479) |
Participants reported their perceived quality of life using a scale 1 - 10, with 1 being the worst and 10 being the best.
| units on a scale | Liver Transplant Patients |
|---|---|
| Baseline | 5.5 ± 2.5 |
| 6 Weeks | 8.25 ± 1.6 |
| 4 months | 8.3 ± 1.6 |
8 participants documented their physical activity at 6 weeks. 6 participants documented their physical activity at 4 months.
| participants | Liver Transplant Patients |
|---|---|
| 6 weeks | 8 |
| 4 months | 6 |
Collected over 4 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Liver Transplant Patients | — | 0/12 (0%) | 0/12 (0%) |
| Age, Categorical(Participants) | Liver Transplant Patients |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 12 |
| >=65 years | 0 |
| Sex: Female, Male(Participants) | Liver Transplant Patients |
|---|---|
| Female | 2 |
| Male | 10 |
| Race (NIH/OMB)(Participants) | Liver Transplant Patients |
|---|---|
| American Indian or Alaska Native | 0 |
| Asian | 1 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 0 |
| White | 10 |
| More than one race | 0 |
| Unknown or Not Reported | 1 |
| Region of Enrollment(participants) | Liver Transplant Patients |
|---|---|
| United States | 12 |
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mayo Clinic